tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Coherus Biosciences (CHRS)
NASDAQ:CHRS
CHRS
Coherus Biosciences
Stock Analysis
Analyst Forecasts
Technical Analysis
Options
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Coherus Biosciences (CHRS) Stock News & Sentiment

1,227 Followers
Coherus Biosciences Embarks on Strategic Financial Restructuring
PremiumCompany Announcements
Coherus Biosciences Embarks on Strategic Financial Restructuring
5d ago
8K
CHRS
Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics’ ENB-003 for the Treatment of Ovarian Cancer
PremiumPress Releases
Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics’ ENB-003 for the Treatment of Ovarian Cancer
6d ago
CHRS
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
7d ago
CHRS
Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
PremiumPress Releases
Coherus to Report First Quarter 2024 Financial Results on May 9, 2024
13d ago
CHRS
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
PremiumPress Releases
Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
20d ago
CHRS
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
PremiumPress Releases
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
1M ago
CHRS
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
PremiumPress Releases
Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update
2M ago
CHRS
More CHRS News >

CHRS News on the Web

Coherus BioSciences First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Yahoo Finance
Neutral
Coherus BioSciences, Inc. Q1 2024 Earnings Call Transcript
Yahoo Finance
Neutral
CHRS Stock Earnings: Coherus BioSciences Misses EPS, Misses Revenue for Q1 2024
InvestorPlace
Neutral
Coherus BioSciences Reports Q1 Loss, Misses Revenue Estimates
Yahoo Finance
Neutral
Coherus BioSciences (CHRS) Reports Q1 Loss, Misses Revenue Estimates
Zacks
Neutral
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
Yahoo Finance
Neutral
Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
Yahoo Finance
Neutral
When Can We Expect A Profit From Coherus BioSciences, Inc. ?
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
CHRS
Sector Average
Media Buzz
This Week10 articles
Weekly Average3 articles
News Sentiment
This Week50%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CHRS’s Media Buzz Sentiment?
10 articles about CHRS were published this week. In an average week, 3 articles are published.
    What is CHRS’s weekly average amount of articles?
    In an average week, 3 articles about CHRS are published.
      What is CHRS’s News Sentiment?
      50% of articles about CHRS were positive this week, compared to its sector average of 61%.
        Healthcare Stocks that are Trending in the News
        CYTKCytokinetics
        MTDMettler-Toledo
        PHVSPharvaris
        IMCRImmunocore Holdings
        HAEHaemonetics
        Showing the stocks with the most bullish news sentiment over the past week

        Get More with TipRanks Premium

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing